Cyclosporine

Cyclosporine

Bibliographic Details
Main Authors:	Russell, N, Knight, SR, Morris, P
Format:	Book section
Published:	Elsevier 2008

Similar Items

The Clinical Benefits of Cyclosporine C2-Level Monitoring: A Systematic Review
by: Knight, S, et al.
Published: (2007)

ABC of monitoring drug therapy. Cyclosporin.
by: Reynolds, D, et al.
Published: (1992)

Cyclosporin for the treatment of severe inflammatory bowel disease.
by: Baker, K, et al.
Published: (1989)

Formation of nanoemulsion system containing cyclosporine for topical treatment of psoriasis
by: Musa, Siti Hajar
Published: (2018)

Colon salvage therapy for acute severe colitis: cyclosporine or infliximab?
by: Burger, D, et al.
Published: (2011)

Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications.
by: Hyde, G, et al.
Published: (2001)

NMR-STUDIES OF THE NA+, MG2+ AND CA2+ COMPLEXES OF CYCLOSPORINE-A
by: Carver, J, et al.
Published: (1992)

Cyclosporin A retention enemas in refractory distal ulcerative colitis and 'pouchitis'.
by: Winter, T, et al.
Published: (1993)

Proteomic analysis of zebrafish (Danio rerio) embryos exposed to cyclosporine A.
by: Ponnudurai, R, et al.
Published: (2012)

Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation.
by: Eisen, H, et al.
Published: (2001)

Modification Of Renal Haemodynamics In Cyclosporine A – Induced Renal Failure Rats By Tempol
by: Tan, Yong Chia
Published: (2013)

Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A
by: Davies, C, et al.
Published: (2000)

Withdrawal of cyclosporine after renal transplantation: A brisk pace may be detrimental
by: Munster, J, et al.
Published: (2007)

Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal?
by: Hyde, G, et al.
Published: (1998)

Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A.
by: Davies, C, et al.
Published: (2000)

Effective use of cyclosporin in sarcoidosis: a treatment strategy based on computed tomography scanning.
by: O'Callaghan, C, et al.
Published: (1994)

Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.
by: Calne, R, et al.
Published: (1999)

The influence of CYP3A gene polymorphisms on cyclosporine dose requirement in renal allograft recipients
by: Eng, H.S., et al.
Published: (2006)

Novel topical nano-colloidal carrier loaded with cyclosporine: biological evaluation potentially for psoriasis treatment
by: Musa, Siti Hajar, et al.
Published: (2021)

Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients.
by: Calder, V, et al.
Published: (1987)

Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients.
by: Calne, R, et al.
Published: (1998)

The Effecttiveness of topical cyclosporine 0.05% compared to topical fluorometholone 0.1% in the therapy of vernal keratoconjunctivitis
by: Perpustakaan UGM, i-lib
Published: (2008)

Histological changes associated with the use of intravenous cyclosporin in the treatment of severe ulcerative colitis may mimic dysplasia.
by: Hyde, G, et al.
Published: (2002)

Therapeutic actions of cyclosporine and anti-tumor necrosis factor alpha in collagen-induced arthritis and the effect of combination therapy.
by: Williams, R, et al.
Published: (1998)

Enhancement of physicochemical properties of nanocolloidal carrier loaded with cyclosporine for topical treatment of psoriasis: in vitro diffusion and in vivo hydrating action
by: Musa, Siti Hajar, et al.
Published: (2017)

Angiotensin II stimulates expression of transcription factors c-Jun and c-Fos in cyclosporine induced human gingival fibroblasts
by: Subramani, Tamilselvan, et al.
Published: (2014)

Impact of tacrolimus versus cyclosporine on one-year renal transplant outcomes : a single-centre retrospective cohort study
by: Ong, Pei Wen, et al.
Published: (2021)

Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation.
by: Pierog, J, et al.
Published: (2005)

Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
by: Knight, SR, et al.
Published: (2009)

T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
by: Novitzky, N, et al.
Published: (2004)

Effect Of Gelucire 44/14 On The Oral Bioavailability Of Cyclosporin A [RM666.C978 L73 2007 f rb ].
by: Lim, Sin Yee
Published: (2007)

Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts.
by: Cozzi, E, et al.
Published: (2003)

Addition of cyclosporin post transplantation decreases GvHD without enhancing the adverse effect of T-cell depletion with CAMPATH-1H "in the bag": The cape town experience
by: Novitzky, N, et al.
Published: (2003)

Azathioprine and Steroids
by: Knight, SR, et al.
Published: (2008)

In response to: Benefit of neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction.
by: Knight, SR, et al.
Published: (2008)

Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis.
by: Knight, SR, et al.
Published: (2010)

Steroid avoidance or withdrawal in renal transplantation.
by: Knight, SR, et al.
Published: (2011)

2-methoxyestradiol TPGS micelles attenuate cyclosporine A-induced nephrotoxicity in rats through inhibition of TGF-β1 and p-ERK1/2 axis
by: Al-Rabia, Mohammed W., et al.
Published: (2022)

Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine.
by: McIntosh, J, et al.
Published: (2012)

Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine
by: McIntosh, J, et al.
Published: (2012)